HIGHLIGHTS
- who: Delmy Oliva and Lasse Jensen from the France Kepler University Hospital GmbH have published the research: Opposing inflammatory biomarker responses to sleep disruption in cancer patients before and during oncological therapy, in the Journal: (JOURNAL)
- what: This aggregated MOS score represents a single value related to the sleep quality of the patient which the authors propose allows a stronger, more robust and intuitive use of the MOS sleep scale compared to the various sub-scale scores that have been used in the past (Agrafiotis et_al, 2022). The authors have evaluated the diagnostic value of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.